Agreement signedAgreed 26 Sep 2023
Alfasigma S.p.A. /
Intercept Pharmaceuticals, Inc.
Alfasigma S.p.A. agrees to buy Intercept Pharmaceuticals, Inc.




01 / BuyerAlfasigma S.p.A.
02 / TargetIntercept Pharmaceuticals, Inc.
What happened
Alfasigma S.p.A. agreed to acquire Intercept Pharmaceuticals, Inc. for $19.00 per Share, according to a filing dated Nov. 8, 2023.
The source
Everything on this page comes from the source below.
01
Source · Original source
Alfasigma S.p.A. agrees to buy Intercept Pharmaceuticals, Inc.
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Announced
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly